James Frith MP: speeches
4 Jul 2026–18 Nov 2026 · year in progress
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Parliamentary contributions: dates and coverage
- Source checked
- 18 Nov 2026
- Last successful import
- 18 Nov 2026
- Records dated through
- 17 Nov 2026
- Selected period
- Reporting year 3: 4 Jul 2026 to 18 Nov 2026
- Completeness
- Published snapshot: 20,352 records in the source window 20 Aug 2026 to 18 Nov 2026. The published snapshot covers its stated source window. Older imports can extend beyond it; not every public speech is included.
This page lists the parliamentary spoken contributions we hold for James Frith in the reporting year 3 (4 Jul 2026 to 18 Nov 2026). It does not include every public speech, party-conference address or constituency event. Latest retained contribution in this period: 17 Nov 2026. The source check date and dataset limits are shown above. Open the Hansard link for the full debate and surrounding context.
Read what this MP said, asked and contributed in Parliament.
67 published records · newest first.
Speeches
- 17 Nov 2026 · NHS Federated Data Platform: Palantir · Read the full contribution in Hansard
More
I thank my hon. Friend, the Chair of the Science, Innovation and Technology Committee, for her questions. I heard her concerns both in yesterday’s contribution and in the subsequent conversation that we had. This has my full attention, because incumbency cannot be allowed to be an advantage by design. I will ensure that the Procurement Act of 2023, which requires equal treatment, has my full attention in the drafting of the procurement.
- 17 Nov 2026 · NHS Federated Data Platform: Palantir · Read the full contribution in Hansard
More
I thank my hon. Friend for her question. This is a decision to procure anew. It is not about other territories or one supplier and their executives holding a political view. It is a decision that is being taken to go to market for a new version—the next generation of FDP. That process began yesterday in earnest. It is not, as I have said, about where else Palantir supplies or who else it has as customers.
- 17 Nov 2026 · NHS Federated Data Platform: Palantir · Read the full contribution in Hansard
More
The data remains NHS, as does the intellectual property, and there is no lock-in. In the announcement yesterday, I confirmed to the House that we are beginning a new procurement process, and I will come on to confirm more details of that. I will now try to make a bit of progress.
- 17 Nov 2026 · NHS Federated Data Platform: Palantir · Hansard source
More
indicated dissent .
- 17 Nov 2026 · NHS Federated Data Platform: Palantir · Read the full contribution in Hansard
More
This contract—a seven-year contract—was awarded in 2023. This is year 3, and we have announced that the contract will end in March 2029. A letter from Palantir to me and Secretary of State confirms in its third paragraph: “The FDP programme team has done a tremendous job of ensuring that exit arrangements are clear, and that the NHS has all the rights and all the support it needs to transition to a new supplier when the contract ends.
- 17 Nov 2026 · NHS Federated Data Platform: Palantir · Read the full contribution in Hansard
More
I thank the hon. Member for Newton Abbot (Martin Wrigley) for raising this important issue. It has been a pleasure exchanging with him, in corridors and more formal settings, on areas where we definitely agree as well as others where we are yet to agree, which I will come on to.
- 17 Nov 2026 · Medicines and Healthcare Products Regulatory Agency · Read the full contribution in Hansard
More
I will make some progress. I am conscious that I need to give the right hon. Member for Tatton time to sum up. We should not assume that the regulator of today is incapable of learning from the regulator of the past. The test that I would apply is whether it listens when patients raise concerns and whether it shows a readiness to reform or renew. That matters for the future as much for the past.
- 17 Nov 2026 · Medicines and Healthcare Products Regulatory Agency · Read the full contribution in Hansard
More
I will make some progress before I take interventions shortly. The issues we have discussed matter enormously. Medicines and medical devices affect us all, often when we are at our most vulnerable. The public must be able to trust the system that regulates those medicines and devices. It must be rigorous, independent and transparent and, when concerns are raised, they must be heard. I acknowledge that the experiences of patients and families that hon. Members have raised remain deeply difficult.
- 17 Nov 2026 · Medicines and Healthcare Products Regulatory Agency · Read the full contribution in Hansard
More
It is a pleasure to serve with you in the Chair, Sir John. I am very grateful to the right hon. Member for Tatton (Esther McVey) and my hon. Friend the Member for Blackley and Middleton South (Graham Stringer) for securing today’s debate. I am also grateful to all Members who have contributed to, not only today’s debate, but this great history of debates on such incredible issues and related injustices.
- 17 Nov 2026 · Medicines and Healthcare Products Regulatory Agency · Read the full contribution in Hansard
More
I am happy to improve transparency and remain accountable to the House on this issue. The MHRA and the Commission on Human Medicines are committed to considering new and relevant scientific information, including recently published material identified in this debate. I will happily pick that up with the hon. Lady shortly. Performance cannot be measure by speed alone. Today, hon.
- 17 Nov 2026 · Medicines and Healthcare Products Regulatory Agency · Hansard source
More
It was remiss of me not to answer the right hon. Lady’s question. I am happy to meet if the diary works for the planned date—otherwise a subsequent one will be found. I am very happy to give that commitment.
- 16 Nov 2026 · Health and Care: Digital Capability · Read the full contribution in Hansard
More
I thank the right hon. Gentleman for his customary selection of very strong questions. It is good to be across the Dispatch Box from him today. I will start with the issue of trust. This is fundamental, because innovation can move only at the speed of trust. I take that incredibly seriously. We are today announcing a new procurement for the next iteration of the FDP programme, which builds on an increased appetite for additional capabilities.
- 16 Nov 2026 · Health and Care: Digital Capability · Hansard source
More
I welcome my hon. Friend’s question. It is absolutely right that we continue to recognise the need for trust in the system to come. Correspondence from Palantir to me and the Secretary of State says that exit arrangements are clear, and that the NHS has all the rights and support that it needs to transition to a new supplier when the contract ends.
- 16 Nov 2026 · Health and Care: Digital Capability · Hansard source
More
We are announcing new procurement for the next generation of FDP. That is the responsible thing to do for continuity of care for patients who are benefiting from the FDP as is. That is the judgment and the announcement that we are making today. This is not, as I said earlier, about the territories in which a company has customer products, or the views of a company’s executives and their politics.
- 16 Nov 2026 · Health and Care: Digital Capability · Hansard source
More
I do not want to second-guess what additional capabilities there could be. Use of the platform now is not compulsory, but it should be compelling. On the additional scope for the next generation of the FDP and the procurement, we have committed to engaging with staff, the workforce, patients, the data guardian and, of course, the House and my fellow MPs, on articulating what should come next. I look forward to those conversations.
- 16 Nov 2026 · Health and Care: Digital Capability · Read the full contribution in Hansard
More
I can confirm that the contract will end in March 2029. I appreciate the distinction that the hon. Gentleman makes on the matter of numbers of trusts. Of the 170 trusts that are signed up, 142 are live—that effectively means they have activated it. Of the 142, 137 are realising benefits. I am happy to write to him with any follow-up data or metrics on which he seeks assurance.
- 16 Nov 2026 · Health and Care: Digital Capability · Read the full contribution in Hansard
More
I thank my hon. Friend not just for his engagement and questions to me today but for his counsel throughout, which has often been in corridors as we pass each other as well as formally. I look forward to further engagement with him and the Health and Social Care Committee on which he serves. We are both excited about the prospect of Government policies improving and enhancing UK sovereign capability.
- 16 Nov 2026 · Health and Care: Digital Capability · Read the full contribution in Hansard
More
As I have said—this is an opportunity to remake the point—we either undermine or underpin, when it comes to data systems and products in this space that the Government are providing to trusts across the country. We should not expect innovation to move faster than trust.
- 16 Nov 2026 · Health and Care: Digital Capability · Read the full contribution in Hansard
More
I thank my hon. Friend for her distinguished contribution, for the work that she leads as Chair of the Science, Innovation and Technology Committee, and for her questions, as well as for the exchange of letters that we are, ourselves, locked into. I can confirm that the contracts we are talking about include exit and transition provisions, that migration is possible in principle, and that NHS-funded IP and supplier background IP are distinct.
- 16 Nov 2026 · Health and Care: Digital Capability · Hansard source
More
My right hon. Friend speaks to the sensitivity of some of the issues discussed today. Procurement starts today. Meetings are happening this week relating to new provider possibilities. There will be market engagement from January, to describe what the next iteration of FDP needs to include. The terms for that procurement will be issued in the coming weeks. I note my right hon. Friend’s request on what those terms should include, and thank him for it.
- 16 Nov 2026 · Health and Care: Digital Capability · Read the full contribution in Hansard
More
I can give the hon. Gentleman that commitment and my full attention to that issue. One benefit of adopting tech, and the roll-out of safely deployed AI in primary care settings, is that doctors are now able to turn and face their patients. They will not sit side-on, tapping away and administering their records; they will be giving their full attention, which will allow them to understand body language or any cues that they need to understand.
- 16 Nov 2026 · Health and Care: Digital Capability · Read the full contribution in Hansard
More
The hon. Member and I agree on the opportunity given to us by a new FDP procurement process. I repeat that part of the opportunity is about fully articulating additional capabilities to realise the productivity benefits and efficiency savings that the FDP, as it exists, is already proving. The decision taken today is based on independent measures of use by 137 trusts.
- 16 Nov 2026 · Health and Care: Digital Capability · Read the full contribution in Hansard
More
I thank my hon. Friend for her championing of our UK sector. She has my full support in those efforts. As I have made clear today, I hope that this decision sparks and stirs interest in new provision and new uptake to be involved in the next iteration of the FDP model. The storing of data is a trust issue.
- 16 Nov 2026 · Health and Care: Digital Capability · Read the full contribution in Hansard
More
The Government are ensuring, whether through the statement from my right hon. Friend the Chancellor, or through commitments made in the House, that their spending goes a long way, and that there is a first-customer principle in our economy. I look forward to that, and I appeal to businesses in my hon.
- 16 Nov 2026 · Health and Care: Digital Capability · Hansard source
More
My hon. Friend has my full assurance that that is now the case in contractual terms. I will take every opportunity to repeat our commitment to security, and to the appropriate and contractual use of data.
Explore activity by topic or department
Contributions by debate topic
4 Jul 2026–18 Nov 2026. Existing keyword taxonomy applied to official debate titles and contributions; a contribution may appear in more than one topic and unclassified records are retained.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →